Home/Filings/4/0001415889-25-015668
4//SEC Filing

Mensinger Mike 4

Accession 0001415889-25-015668

CIK 0001674632other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 7:30 PM ET

Size

9.0 KB

Accession

0001415889-25-015668

Insider Transaction Report

Form 4
Period: 2025-06-02
Mensinger Mike
Chief Product Officer
Transactions
  • Sale

    Common Stock

    2025-06-02$18.69/sh101$1,88892,904 total
  • Sale

    Common Stock

    2025-06-02$18.15/sh708$12,84993,005 total
  • Sale

    Common Stock

    2025-06-02$17.03/sh306$5,21193,713 total
Footnotes (4)
  • [F1]The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • [F2]The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F3]The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F4]The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Issuer

Beta Bionics, Inc.

CIK 0001674632

Entity typeother

Related Parties

1
  • filerCIK 0002048500

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 7:30 PM ET
Size
9.0 KB